A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,292 shares of RCKT stock, worth $56,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,292
Previous 2,710 21.48%
Holding current value
$56,787
Previous $58,000 3.45%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$17.6 - $25.88 $10,243 - $15,062
582 Added 21.48%
3,292 $60,000
Q2 2024

Jul 30, 2024

SELL
$20.66 - $26.72 $6.18 Million - $7.99 Million
-299,122 Reduced 99.1%
2,710 $58,000
Q1 2024

May 01, 2024

BUY
$26.16 - $30.74 $3.38 Million - $3.98 Million
129,358 Added 75.0%
301,832 $8.13 Million
Q4 2023

Jan 24, 2024

SELL
$16.78 - $31.94 $3.61 Million - $6.87 Million
-215,230 Reduced 55.51%
172,474 $5.17 Million
Q3 2023

Oct 26, 2023

BUY
$15.07 - $24.05 $477,010 - $761,254
31,653 Added 8.89%
387,704 $7.94 Million
Q2 2023

Aug 10, 2023

BUY
$16.59 - $23.6 $854,949 - $1.22 Million
51,534 Added 16.92%
356,051 $7.07 Million
Q1 2023

May 04, 2023

BUY
$15.79 - $22.6 $317,126 - $453,898
20,084 Added 7.06%
304,517 $5.22 Million
Q4 2022

Feb 09, 2023

SELL
$15.5 - $22.76 $882,926 - $1.3 Million
-56,963 Reduced 16.69%
284,433 $5.57 Million
Q3 2022

Nov 10, 2022

BUY
$12.37 - $18.41 $969,758 - $1.44 Million
78,396 Added 29.81%
341,396 $5.45 Million
Q2 2022

Jul 26, 2022

BUY
$7.96 - $16.64 $173,591 - $362,885
21,808 Added 9.04%
263,000 $3.62 Million
Q1 2022

May 10, 2022

SELL
$13.16 - $23.68 $410,749 - $739,100
-31,212 Reduced 11.46%
241,192 $3.83 Million
Q4 2021

Feb 08, 2022

BUY
$21.52 - $36.02 $1.35 Million - $2.27 Million
62,896 Added 30.02%
272,404 $5.95 Million
Q3 2021

Nov 15, 2021

BUY
$27.42 - $48.97 $1.2 Million - $2.15 Million
43,930 Added 26.53%
209,508 $6.26 Million
Q2 2021

Aug 11, 2021

BUY
$39.41 - $47.25 $1.16 Million - $1.39 Million
29,500 Added 21.68%
165,578 $7.33 Million
Q1 2021

May 13, 2021

BUY
$43.34 - $65.91 $3.17 Million - $4.82 Million
73,124 Added 116.15%
136,078 $6.04 Million
Q4 2020

Feb 10, 2021

BUY
$23.3 - $59.57 $323,963 - $828,261
13,904 Added 28.35%
62,954 $3.45 Million
Q3 2020

Nov 12, 2020

BUY
$20.5 - $28.59 $324,392 - $452,408
15,824 Added 47.63%
49,050 $1.12 Million
Q2 2020

Aug 11, 2020

BUY
$13.32 - $22.61 $181,032 - $307,292
13,591 Added 69.22%
33,226 $696,000
Q1 2020

May 12, 2020

BUY
$9.71 - $25.11 $20,847 - $53,911
2,147 Added 12.28%
19,635 $274,000
Q4 2019

Feb 12, 2020

BUY
$11.07 - $24.23 $36,464 - $79,813
3,294 Added 23.21%
17,488 $398,000
Q3 2019

Nov 12, 2019

BUY
$10.85 - $14.78 $154,004 - $209,787
14,194 New
14,194 $165,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.31B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.